Timothy Pluard, MD
- Breast Medical Oncology
- Saint Luke's Hospital of Kansas City
- Saint Luke's North Hospital
- Saint Luke's East Hospital
- Hedrick Medical Center
Make an Appointment
Locations
Saint Luke's Cancer Specialists
Saint Luke's Cancer Specialists
About Timothy Pluard, MD
I joined Saint Luke's Cancer Institute as medical director in August 2013. Previously, I was Associate Professor of Medicine and Clinical Director of Breast Oncology at Washington University/Siteman Cancer Center in St. Louis. I am interested in clinical research studies of new targeted therapies of breast cancer. The care of women with breast cancer requires a multidisciplinary holistic approach from diagnosis through treatment, recovery, and survivorship. At Saint Luke's Cancer Institute, we have a superb team focused on the comprehensive care of women with breast cancer.
Publications
Peer Reviewed Manuscripts
Adkins D, Brown R, Trinkaus K, Maziarz R, Leudke S, Freytes C, Needles B, Fracasso P, Pluard T, Moriconi W, Ryan T, Hoelzer K, Safdar S, Rearden T, Rodriguez G, Khoury H, Vij R, DiPersio J: Outcomes of high-dose chemotherapy and autologous stem-cell transplantation in stage IIIB inflammatory breast cancer. J Clin Oncol 17:2006-2014;1999.
O'Reilly EM, Niedzwiecki D, Hall M, Hollis D, Bekaii-Saab T, Pluard T, Douglas K, Abou-Alfa GK, Kindler HL, Schilsky RL, Goldberg RM; for the Cancer and Leukemia Group B: A Cancer and Leukemia Group B phase II study of sunitinib malate in patients with previously treated metastatic pancreatic adenocarcinoma. Oncologist. 2010 Dec 10. [Epub ahead of print]
Fracasso PM, Williams KJ, Chen RC, Picus J, Ma CX, Ellis MJ, Tan BR, Pluard TJ, AdkinsDR, Naughton MJ, Rader JS, Arquette MA, Fleshman JW, Creekmore AN, Goodner SA, Wright LP, Guo Z, Ryan CE, Tao Y, Soares EM, Cai SR, Lin L, Dancey J, Rudek MA, McLeod HL, Piwnica-Worms H., A phase I study of UCN-01 in combination with irinotrecan in patients with resistant solid tumor malignancies. Cancer Chemother Pharmocol 2010 Aug 8 [ Epub ahead of print]
Aft R, Naughton M, Trinkaus K, Watson M, Ylagan L, Chavez-MacGregor M, Zhai J, Kuo S, Shannon W, Diemer K, Herrmann V, Dietz J, Ali A, Ellis M, Weiss P, Eberlein T, Ma C, Fracasso PM, Zoberi I, Taylor M, Gillanders W, Pluard T, Mortimer J, Weilbaecher K.: Effect of Zoledronic Acid on disseminated tumor cells in women with locally advanced breast cancer: an open label, randomized phase 2 trial. Lancet Oncol May; 11(5):421-8.
Fleming GF, Ma CX, Huo D, Sattar H, Tretiakova M, Lin L, Hahn OM, Olopade FO,Nanda R, Hoffman PC, Naughton MJ, Pluard T, Conzen SD, Ellis MJ. Phase II trial of temsirolimus in patients with metastatic breast cancer. Breast Cancer Res Treat. 2012 Nov;136(2):355-63. doi: 10.1007/s10549-011-1910-7. Epub 2012 Jan 13.
Al Mushawah F, Rastelli A, Pluard T, Margenthaler JA. Metastatic invasive breast cancer recurrence following curative-intent therapy for ductal carcinoma in situ. J Surg Res. 2012 Mar;173(1):10-5. doi: 10.1016/j.jss.2011.04.058. Epub 2011 May 23. PubMed PMID: 21696764.
Abstracts
O'Reilly EM, Niedzwiecki D, Hollis DR, Bekaii-Saab TS, Pluard T, Duffy A, Overcash F, Ivy SP, Goldberg RM. A pahse II trial of sunitinib in previously-treated pancreas adenocarcinoma (PAC), CALGB 80603. J Clin Oncol 26:2008 (May 20 suppl; abstr 4515).
T. A. Samuel, C. Sessa, C. Britten, K. S. Milligan, M. M. Mita, U. Banerji, T. J. Pluard, P. Stiegler, C. Quadt, G. Shapiro; A phase I dose escalation study of AUY922, a novel HSP90 inhibitor in patients with advanced solid malignancies. J Clin Oncol 27:15s, 2009 (suppl; abstr 3532)
Tan BR, Myerson R, Linehan D, Hawkins W, Pluard T, Fournier C, James J, Strasberg S, Picus J. Adjuvant gemcitabine plus docetaxel followed by 5FU chemoradiation for patients with resected pancreaticobiliary cancers: A single-institution phase II study. ASCO 2008 GastrointestinalCancers Symposium, Abstract No. 237.
Hahn OM, Ma CX, Lin L, Sattar H, Olopade FO, Nanda R, Hoffman PC, Naughton MJ, Pluard TJ, Watson MA, Ellis M, Conzen SD, Fleming GF: A Phase II Trial of a mammalian target of rapamycin inhibitor, temsirolimus, in patients with metastatic breast cancer. SABCS, 2008 Abstract # 407
C. Sessa, S. K. Sharma, C. D. Britten, N. J. Vogelzang, K. N. Bhalla, M. M. Mita, T. J. Pluard, P. Stiegler, C. Quadt, G. I. Shapiro; A phase I dose escalation study of AUY922, a novel HSP90 inhibitor, in patients with advanced solid malignancies. ; J Clin Oncol 27:15s, 2009 (suppl; abstr 3532)
Burstein HJ, Barry WT, Cirrincione C, Chew HK, Tolaney S, Lake D, Pluard T, Blackwell K, Winer EP, Hudis CA. CALGB 40302: Fulvestrant with or without Lapatinib as Therapy for Hormone Receptor Positive Advanced Breast Cancer: A Double-Blinded, Placebo-Controlled, Randomized Phase III Study; Cancer Research 70(24) 109s
Roop R, Naughton M, Schneider J, Lammers P, Pluard T, Johnson F, Eby C, Weilbaecher K. Effect of Platelet Function Inhibition on Circulating Tumor Cells in Patients with Metastatic Breast Cancer: A Randomized Phase II Trial. ; Cancer Research 70(24) 250s
Ellis M, Suman V, McCall L, Luo R, Brink A, Watson M, Ma C, Unzeitig G, Pluard T, Whitworth P, Babiera G, Guenther M, Leitch M, Ota D, Olson J, Hunt K, Allred, C.: Z1031B Neoadjuvant Aromatase Inhibitor Trial: A Phase 2 study of Triage to Chemotherapy based on 2 to 4 week ki67 level >10% Presented at SABCS 2012
Invited Publications
Fine HA, Pluard TJ: Tumor angiogenesis: Biology and therapeutic implications In: Mauch P, Loeffler J, (eds.). Radiation Oncology: Theory and Practice.
Fehniger T, Welch J, Pluard T. Hematologic Malignancies: Chronic Leukemias. The Washington Manual of Oncology, 2nd edition, 319, 2008.
Education & Credentials
Training & Education
-
Residency
University of Texas Southwestern Med School
-
Fellowship
Dana-Farber Cancer Institute (Harvard Medical School)
-
Medical School
Washington University School of Medicine
Accepted Insurance Plans
Browse the list below to view insurance plans.
Before scheduling your appointment, we recommend you contact your health insurance company to confirm your policy's network, copays, coinsurance, deductibles, or out-of-network benefits. If you are uninsured, please contact us to learn more about our financial assistance policy.
Aetna
- Aetna Choice POS II Local (excluding National General STM plan, I-35 Preferred Plan, and HCA, Advent Health, and NKC Hospital employee plans)
- Aetna Elect Choice
- Aetna HMO
- Aetna Managed Choice
- Aetna Medicare Assure (HMO)
- Aetna Medicare Core Value HMO
- Aetna Medicare Premier Preferred HMO
- Aetna Medicare Premier and Premier Plus HMO
- Aetna Open Choice (PPO)
- Aetna Select
- Aetna Signature Administrators (ASA)
- Aetna UAW Retiree Medical Benefits Trust (Medicare Advantage HMO, PPO)
- Aetna Workers Comp
Blue Cross
- BCBS of Kansas
- BCBS of Kansas Blue Choice Preferred Care Blue PPO
- BCBS of Kansas City Blue Select Plus (UCMO and City of KCMO)
- BCBS of Kansas City Federal PPO
- BCBS of Kansas City Freedom Network PPO
- BCBS of Kansas City Freedom Network Select PPO
- BCBS of Kansas City Preferred Care
- BCBS of Kansas City Preferred Care Blue
- BCBS of Kansas City Traditional
- BCBS of Kansas Federal
- BCBS of Kansas Traditional
- BCBS of Michigan Medicare Advantage PPO
Cigna
- Cigna HMO
- Cigna OAP
- Cigna PPO
- Great West Healthcare
Corvel
- Corvel
First Health Network
- First Health Network
Home State
- Home State Health Plan (Missouri Medicaid)
Humana
- Humana Gold Choice PFFS
- Humana Gold Plus HMO SNP - Medicare Advantage
- Humana Medicare Advantage Team Care Gold HMO
- Humana Medicare Advantage Team Care Gold PPO
MHNet
- Healthy Blue MO Medicaid
- MH Net Behavioral Health
Medicare
- American Health Advantage-Missouri Medicare Advantage
- Devoted Health Medicare Advantage (Core and Giveback)
- Kansas Health Advantage/Kansas Superior Select, Inc (KSSI) Medicare Advantage
- Medicare
MultiPlan
- MultiPlan
Orscheln Industries
- HealthSCOPE Benefits (Orsheln Industries)
Other
- BeechStreet
- Century Health Solutions (PPO)
- CompResults/CompAlliance (WC) PPO
- Health Choice of Northwest Missouri (PPO)
- Integrated Health Plan PPO
- Medica Connect
- Medica Select
- OHA Networks (WC)
- OHARA Managed Care (WC)
- Occupational Health Management PPO (WC)
- Private Healthcare Systems (PHCS)
- ProviDRs Care Network PPO (formerly WPPA)
- Provider Partners Health Plan
- Sunflower State Health Plan Kansas Medicaid
Other Medicaid
- Healthy Blue KS Medicare Advantage DSNP
- Healthy Blue Kansas Medicaid
TriWest
- TriWest
United Healthcare
- UHC Medicare Erickson Advantage plans-KC
- United HealthCare Choice
- United HealthCare Choice Plus
- United HealthCare Community Plan (Missouri Medicaid)
- United HealthCare Navigate
- United HealthCare Select
- United HealthCare Select Plus
- United Healthcare - AARP Medicare Advantage Choice Plans
- United Healthcare - AARP Medicare Advantage Patriot
- United Healthcare - All Savers Insurance
- United Healthcare - Community Plan (Kansas Medicaid)
- United Healthcare - Core and Core Essential
- United Healthcare - Definity Health Reimbursement Account POS
- United Healthcare - Definity Health Savings Account POS
- United Healthcare - Golden Rule HMO (HMO & PPO)
- United Healthcare - Options PPO
- United Healthcare - United Health One
- United Healthcare Individual Exchange Benefit Plan (IEX) MO and KS Plans
- UnitedHealthcare - AARP Medicare Complete Choice
- UnitedHealthcare - AARP Medicare Complete HMO
- UnitedHealthcare - AARP Medicare Complete PPO
- UnitedHealthcare - Dual Complete SNP PPO (MO and KS)
- UnitedHealthcare - Group Medicare Advantage PPO
- UnitedHealthcare - Medicare Complete
- UnitedHealthcare - Medicare Gold SNP
- UnitedHealthcare - Medicare Silver SNP
Reviews & Ratings
Recent Patient Reviews
The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
We refer to Saint Luke’s providers as well as independent providers credentialed at a Saint Luke’s facility. Providers make no payments for these referrals and our selections are based on your needs and preferences.